Table 2:
Covariate | N | Hazard ratio (95% CI) | P |
---|---|---|---|
Progression-free survival* | |||
MAP score | 134 | 1.01 (0.85–1.20) | 0.926 |
IVC tumor thrombus | |||
Yes | 65 | 1.55 (0.98–2.47) | 0.061 |
No | 76 | – | – |
Received systemic therapy | |||
Yes | 46 | – | – |
No | 88 | 0.28 (0.18–0.46) | <0.001 |
Corrected calcium | 134 | 1.38 (0.98–1.94) | 0.064 |
Overall survival** | |||
MAP score | 141 | 1.01 (0.84–1.21) | 0.917 |
IVC tumor thrombus | |||
Yes | 65 | 2.05 (1.23–3.39) | 0.006 |
No | 76 | – | – |
MAP, Mayo Adhesive Probability; IVC, Inferior vena cava; ECOG, Eastern Cooperative Oncology Group; BMI, Body mass index. *Backward selection with an alpha level of removal of 0.1 was used. The following variables were removed from the model: Age at the Surgery, BMI, clear_cell, ECOG PS at presentation, Gender, Race, and Side of kidney. **Backward selection with an alpha level of removal of 0.1 was used. The following variables were removed from the model: Age at the Surgery, BMI, clear_cell, ECOG PS at presentation, Gender, Race, Ever received systemic therapy, and Side of Kidney.